The drugmaker believes the move would attract more American investors, who own nearly half its share capital, by elevating its profile among US capital markets.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.